FINALIST FOR THE PULITZER PRIZE For most living Americans, September 11, 2001, is the darkest date in the nation’s history. But what exactly happened on 9/11? Could it have been prevented? And what remains unresolved? Here is the first panoramic, authoritative account of that tragic day—from the first brutal actions of the hijackers to our government’s flawed response; from the untruths told afterward by U.S. officials to the “elephant in the room” of the 9/11 Commission’s report—the clues that point to foreign involvement. New York Times bestselling authors Anthony Summers and Robbyn Swan write with access to thousands of recently released official documents, raw transcripts, fresh interviews, and the perspective that can come only from a decade of research and evaluation. Riveting, revelatory, and thoroughly sourced, The Eleventh Day is updated for this edition—with new reporting on a development that the former cochairman of Congress’s 9/11 probe calls the most important in years. This is the essential one-volume work, required reading for us all. “Essential.”—The Wall Street Journal “Meticulous, comprehensive . . . an extraordinary synthesis.”—John Farmer, 9/11 Commission senior counsel “This wide-angle look . . . examines the personalities behind the terror plot, U.S. intelligence blunders, the toxic environmental impact on first responders, the march to war, [and] gray areas in the 9/11 Commission Report.”—The Washington Post “The best available general account of 9/11—soberly written, judiciously weighed, meticulously sourced.”—The Sunday Times
The role of business in American politics has provoked much controversy and attention over recent years. One need look no further than the Koch brothers or the Trump administration to get an idea of the extent to which the interests of private business wield influence over the political system. Contemporary evidence of the clear and growing disparities in wealth between ordinary citizens and business elites has drawn new attention to this topic. Recently, the canon on the activities of business elites in politics has also grown as we have learned a great deal about how business firms and their ultra-wealthy leaders and investors seek to exert political influence. This book looks at one form of business elite activity that has thus far received little attention, despite the high-profile political efforts of billionaire businesspeople including Bill Gates, Elon Musk, and Mark Zuckerberg: a phenomenon that Darren R. Halpin and Anthony J. Nownes call new entrepreneurial advocacy. This "entrepreneurial advocacy" is a mode of political engagement in which wealthy entrepreneurs (often from Silicon Valley) use their vast resources to form new organizations that advocate for their vision of the social good, which may or may not be directly linked to their private or business interests. While previous studies focus on a cross section of either the wealthiest Americans or the largest firms in the United States, this book takes a deep-dive into the political activities of a single, yet pivotal, cohort--the founders and CEOs of Silicon Valley firms. Specifically, the authors trace the development of new entrepreneurial advocacy to understand its extent, its breadth, and whose interests they represent, who supports them financially, and why business elites choose to create new organizations to engage in advocacy rather than do so under the umbrellas of their companies. Crucially, the authors also look at the impact of these organizations and what their activity means for American democracy. Leveraging a vast range of unique datasets, from political donations and lobbying to philanthropic giving and social media commentary, this book examines the role of this important set of elites in contemporary American political life.
Drawing on the principles of humanistic management, the present volume intends to describe the steps to be taken to transform a company into a social organization, be it private or public. The book consists of three parts, which are preceded by an introduction to the key concepts of Management 2.0. Part I describes the five steps which are necessary for a strategic and organizational transformation, while Part II shows how the function of HRM must change to adapt management and development processes to the dynamics of collaborative work. Part III presents the most important principles and values on which new behaviors, skills, and styles of leadership 2.0 should be based. Each chapter is supplemented with case studies from a number of managers, which evinces that the processes described are feasible in Italy and have already been implemented by far-sighted employers who were able to foretell change.
The mysterious world of fungi is once again unearthed in this expansive second edition. This textbook provides readers with an all-embracing view of the kingdom fungi, ranging in scope from ecology and evolution, diversity and taxonomy, cell biology and biochemistry, to genetics and genomics, biotechnology and bioinformatics. Adopting a unique systems biology approach - and using explanatory figures and colour illustrations - the authors emphasise the diverse interactions between fungi and other organisms. They outline how recent advances in molecular techniques and computational biology have fundamentally changed our understanding of fungal biology, and have updated chapters and references throughout the book in light of this. This is a fascinating and accessible guide, which will appeal to a broad readership - from aspiring mycologists at undergraduate and graduate level to those studying related disciplines. Online resources are hosted on a complementary website.
Multiple sclerosis is the most common cause of neurological disability in young and middle-aged adults. This fully updated and revised new edition provides a detailed account of the many neuropsychiatric disorders associated with MS and is relevant to both the research and the clinical setting. Using the latest brain imaging findings and results from treatment trials, the symptoms, assessment, diagnosis, and treatment of depression in MS are covered, as are psychosocial factors and the link between depression and MRI abnormalities. Subsequent chapters focus on cognitive dysfunction in MS, including the natural history of cognitive change, the use of screening instruments and neuropsychological batteries, brain imaging correlations and management strategies. The book concludes with a survey of the behavioral benefits and risks associated with disease-modifying drugs. It will be valuable to all mental health professionals, neurologists, and others caring for those affected by MS.
The book discusses how labour law and welfare systems will be affected by the ongoing transformation of work. The first section considers demography from two different perspectives. On the one hand, it focuses on chronic diseases and their impact on work, emphasising the role and the regulation of welfare systems. On the other, attention is given to youth unemployment and to those forms of employment which might have an impact on young people. Section II touches upon the relationship between the environment and industrial relations, while the third part broaches the topic of the impact of technology in the context of the Fourth Industrial Revolution, also known as Industry 4.0. As such, this volume provides an exhaustive picture of the changes currently underway, considering all the aspects which will affect work now and in the future.
This brand-new text provides you with an easy-to-use, comprehensive reference that features a clinical perspective balanced with relevant basic science. Inside, you'll find discussions of the latest research and how it has led to a greater understanding of the cause of disease, as well as burgeoning tests and the latest therapeutic agents available. From Alzheimer's disease to vestibular system disorders, you'll find the practical guidance you need to diagnose effectively and provide an appropriate therapeutic approach for each individual case. Plus, a templated, four-color design offers you easy access to pertinent information Integrates basic science with clinical neurology to help you better understand neurologic diseases and provide the most accurate diagnosis and best treatment plan for each patient. Discusses the latest research results and offers new information on treatment options. Features the expertise of international authorities, providing a worldwide perspective. Uses a templated, four-color format that makes information accessible and easy to understand—particularly the basic science concepts.
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.